Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme

Josephine Bourner, Festus Devincy Redji Mbrenga, Christian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, Piero Olliaro
doi: https://doi.org/10.1101/2022.11.28.22282846

Article Information

doi 
https://doi.org/10.1101/2022.11.28.22282846
History 
  • November 29, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Josephine Bourner*,1,†,
  2. Festus Devincy Redji Mbrenga*,2,
  3. Christian Noël Malaka2,
  4. Jake Dunning1,
  5. Amanda Rojek1,
  6. Emmanuel Fandema3,
  7. Peter Horby1,
  8. Yap Boum II2,
  9. Emmanuel Nakouné2 and
  10. Piero Olliaro1
  1. 1Pandemic Sciences Institute, University of Oxford, United Kingdom
  2. 2Institut Pasteur de Bangui, Central African Republic
  3. 3Ministry of Health, Central African Republic
  1. ↵†Corresponding author
    Josephine Bourner, josephine.bourner{at}ndm.ox.ac.uk

  1. ↵* (contributed equally)

Back to top
Posted November 29, 2022.
Download PDF
Data/Code
Email
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
Josephine Bourner, Festus Devincy Redji Mbrenga, Christian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, Piero Olliaro
medRxiv 2022.11.28.22282846; doi: https://doi.org/10.1101/2022.11.28.22282846
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area